Logo der Universität Basel

Research Database / FORSCHUNGSDATENBANK 
PRINTDOC
 
Publication 1194550 | Verified
 

Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1194550
Author(s) Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Culakova, Eva; Lyman, Gary H
Author(s) at UniBasel Schwenkglenks, Matthias
Year 2010
Title Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
Journal Journal of hematology & oncology
Volume 3
Pages / Article-Number 27
Abstract In newly diagnosed patients with Hodgkin lymphoma (HL) the effect of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD)-related neutropenia on chemotherapy delivery is poorly documented. The aim of this analysis was to assess the impact of chemotherapy-induced neutropenia (CIN) on ABVD chemotherapy delivery in HL patients.
Publisher Biomed Central
ISSN/ISBN 1756-8722
edoc-URL http://edoc.unibas.ch/dok/A6004764
Full Text on edoc No
Digital Object Identifier DOI 10.1186/1756-8722-3-27
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/20723212
ISI-Number WOS:000282347000001
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.329 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
10/05/2024